Drug Safety Oversight Board Meeting
April 6, 2006
Public Summary
The Executive Director updated the Board on
patient information and healthcare professional sheets
(described below as “sheets”) and Public Health Advisories (PHAs)
posted since the last meeting, and the Board discussed several
of the actions. The drugs for which sheets and/or PHAs were
posted included gatifloxacin (Tequin) and diazepam rectal gel (Diastat
AcuDial). The Board also discussed other emerging safety issues
and strategies being considered to manage and track identified
safety issues in CDER
DSOB Meeting Summaries
Date created: April 12,
2006  |
